Mandel Sher - Concepedia

Author

Mandel Sher

Also Known As

Huang, Shu, Iftikhar Hussain, M R Sher, M. Sher, M.R. Sher, Mandel R Sher, Mandel R. Sher, Mandel Sher, Sher, Mandel R, Sher, Mandel R.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Florida Center for Gastroenterology Queen's University Belfast Manchester University NHS Foundation Trust Merck & Co., Inc., Rahway, NJ, USA (United States)Hull York Medical School

About

Mandel Sher is an author at Florida Center for Gastroenterology specializing in medicine, allergy, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	9	852
2	Allergy	3	3	124
3	Pharmacology	3	4	476
4	Immunology	2	2	72
5	Allergy Medicine	1	1	85

Mandel Sher

Publications

949

Citations

H-Index

Page 1

	Year	Citations
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial John A. Smith, Michael M. Kitt, Alyn H. Morice, The Lancet Respiratory Medicine AsthmaPulmonary CarePhase 2BPharmacologyUnexplained Chronic Cough	2020	216
Gefapixant in two randomised dose-escalation studies in chronic cough John A. Smith, Michael M. Kitt, P. Butera, European Respiratory Journal	2020	130
Pulmonary vascular disease in complete atrioventricular canal defect Edgar A. Newfeld, Mandel Sher, Milton H. Paul, The American Journal of Cardiology Pulmonary CirculationPulmonary MedicineMedicineCardiologyPulmonary Vascular Disease	1977	119
Diversity in presenting manifestations of systemic lupus erythematosus in children Shahid Iqbal, Mandel Sher, Robert A. Good, The Journal of Pediatrics RheumatologyClinical FindingAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus Treatment	1999	100
Severe food allergies by skin contact Belen M. Tan, Mandel Sher, Robert A. Good, Annals of Allergy Asthma & Immunology Food AllergyAllergySkin ContactAllergy MedicinePeanut Allergy	2001	85
Intravenous immunoglobulin therapy: magic or black magic. Karyl S. Barron, Mandel Sher, E D Silverman PubMed VasculitisIntravenous ImmunoglobulinImmunologyDermatologyImmunotherapy	1992	43
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant Alyn H. Morice, Surinder S. Birring, John A. Smith, Lung	2021	39
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough Lorcan McGarvey, John A. Smith, Alyn H. Morice, Lung	2022	38
EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps Mandel Sher, Gary C. Steven, J. Lewis Romett, Rhinology Journal	2019	36
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough Lorcan McGarvey, Mandel Sher, Yury Grigorievich Shvarts, Lung	2023	34

Page 1